Holen Sie sich die Stockscreener-App
4.595
3.67%
-0.175
Handel nachbörslich:
4.79
0.195
+4.24%
Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten
Larimar Advances Nomlabofusp Toward 2026 BLA Submission - The Globe and Mail
Larimar Therapeutics posts updated corporate deck outlining nomlabofusp BLA plan, Q2 2026 topline and cash runway - TradingView
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
ETF Watch: Is Larimar Therapeutics Inc. stock a good choice for value investorsMarket Movers & Verified Swing Trading Watchlists - Naître et grandir
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month? - TradingView
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March - Sahm
Larimar surges on FDA breakthrough status for lead asset - MSN
Larimar Therapeutics Launches $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Global Legal Chronicle
Larimar Therapeutics price target raised to $12 from $11 at Wedbush - Yahoo Finance
FDA Grants Breakthrough Status to Larimar’s Nomlabofusp - MyChesCo
Wedbush Maintains Outperform on Larimar Therapeutics, Inc. (LRMR) March 2026 - Meyka
Biotech Larimar heads to Miami for back-to-back investor meetings in March - Stock Titan
LRMR Stock Rating Maintained Outperform by Wedbush, Price Target - GuruFocus
Wedbush raises Larimar Therapeutics stock price target to $12 By Investing.com - Investing.com Canada
Wedbush raises Larimar Therapeutics stock price target to $12 - Investing.com
Larimar Therapeutics (NASDAQ:LRMR) Price Target Raised to $12.00 - MarketBeat
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering and Insider Purchases - Quiver Quantitative
LRMR News & Events - Intellectia AI
Larimar Therapeutics: Deerfield entities buy $25m in stock By Investing.com - Investing.com South Africa
Larimar Therapeutics: Deerfield entities buy $25m in stock - Investing.com Nigeria
James Flynn Acquires 5,000,000 Shares of Larimar Therapeutics (NASDAQ:LRMR) Stock - MarketBeat
Insider Buying: Frank Thomas Acquires Additional Shares of Larim - GuruFocus
Wedbush Adjusts Larimar Therapeutics PT to $12 From $11, Maintains Outperform Rating - marketscreener.com
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? - Yahoo Finance
Larimar Therapeutics Announces Upsized Public Equity Offering - TipRanks
Larimar Therapeutics Prices $5.00 Public Offering, Nets ~$107.6 Million as Option Is Exercised - TradingView
Larimar Therapeutics stock dips after pricing $100M share offering - MSN
Larimar Therapeutics prices $100M stock offering at $5 per share - Investing.com Australia
Larimar Therapeutics Prices Upsized $100 Million Public Stock Offering - marketscreener.com
Larimar Therapeutics stock falls 8% on upsized $100 million offering By Investing.com - Investing.com Canada
What is Lifesci Capital's Estimate for LRMR FY2025 Earnings? - MarketBeat
Larimar Therapeutics Prices Upsized 20 Mln Public Offering At $5.00 Per Share, Stock Down - Nasdaq
Larimar Therapeutics (LRMR) Upsizes Public Offering to Raise $10 - GuruFocus
Larimar Therapeutics announces pricing of upsized $100 million underwritten public offering - marketscreener.com
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy - Stocktwits
LRMR Expands Offering to $100 Million - GuruFocus
Larimar Therapeutics Prices Upsized Public Offering - Intellectia AI
Larimar Therapeutics, Inc. Prices Upsized Public Offering of 20 Million Shares at $5.00 Each - Quiver Quantitative
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - Stock Titan
Larimar Therapeutics launches $75M public stock offering By Investing.com - Investing.com Australia
Larimar Therapeutics Announces Pricing Of Upsized $100 Million Underwritten Public Offering - TradingView
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - Benzinga
Larimar Therapeutics launches proposed $75 million public offering - MSN
Press Release: Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - 富途牛牛
Larimar Therapeutics launches $75M public stock offering - Investing.com
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - Bitget
Rare-disease biotech Larimar seeks $75M to fund key drug - Stock Titan
Citigroup Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $14.00 - MarketBeat
LRMR Analyst Update: Citigroup Raises Price Target for Larimar T - GuruFocus
Laminar Therapeutics Stock Is Popping Today: What's Going On? - Benzinga
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):